FBRX
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- FB102 demonstrated statistically significant improvement in vitiligo at Week 24 following a 12-week treatment periodJul 9, 2026
- Forte Biosciences presents FB102 celiac disease trial at Tampere Celiac Disease SymposiumSep 15, 2025
- Forte Biosciences announces positive data from FB102 Phase 1B study in celiac diseaseJun 23, 2025